EAGLE ASSET MANAGEMENT INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$26,726,000
-35.1%
1,437,681
-14.6%
0.14%
-37.4%
Q1 2019$41,155,000
-5.9%
1,683,924
-0.1%
0.22%
-20.4%
Q4 2018$43,728,000
-20.6%
1,685,751
-3.1%
0.28%
+3.4%
Q3 2018$55,052,000
-19.2%
1,739,430
-0.8%
0.27%
-27.5%
Q2 2018$68,094,000
+36.2%
1,752,755
-3.3%
0.37%
+34.9%
Q1 2018$50,005,0001,811,7890.27%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders